REQUEST A DEMO
Total
USD $0.00
Search more companies

Fomat Medical Research S.A. (Ecuador)

Main Activities: General Medical and Surgical Hospitals
Full name: Fomat Medical Research S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Fomat Medical Research is an Integrated Research Organization with over 10 years of experience in clinical research. The company conducts clinical trials for the development of vaccines, medical devices, and treatments. They claim to collaborate with industry leaders to bring new therapies into clinical trials and have expertise in Phase 1 through Phase 4 clinical trials in various therapeutic areas.

Headquarters
Av. Miguel H. Alcivar, Torre a Bldg. , Floor 402
Guayaquil; Guayas;

Contact Details: Purchase the Fomat Medical Research S.A. report to view the information.

Website: http://www.fomatmedical.com

Basic Information
Total Employees:
Purchase the Fomat Medical Research S.A. report to view the information.
Outstanding Shares:
Purchase the Fomat Medical Research S.A. report to view the information.
Registered Capital:
Purchase the Fomat Medical Research S.A. report to view the information.
Incorporation Date:
January 18, 2013
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
66%
Purchase this report to view the information.
34%
Company Performance
Financial values in the chart are available after Fomat Medical Research S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
5.21%
Total operating revenue
5.21%
Operating profit (EBIT)
N/A
EBITDA
N/A
Net Profit (Loss) for the Period
192.43%
Total assets
-32.88%
Total equity
2.8%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
0.02%
Return on Equity (ROE)
1.76%
Debt to Equity Ratio
-338.25%
Quick Ratio
0.12%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?